Feasibility and safety of introducing cashew nut spread in infant diets—A randomized trial
Pediatric Allergy and Immunology · 2023
DOI: 10.1111/pai.13969 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Allergy and Immunology, 2023. Verfasst von Debra J Palmer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Telethon Kids Institute, Nedlands, Western Australia, Australia. Hauptthemen laut MEDLINE: Nut Hypersensitivity, Peanut Hypersensitivity, Food Hypersensitivity, Anacardium. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Australian Food Allergy Foundation, Channel 7 Telethon Trust, Commonwealth Government of Australia.
Abstract (Originalsprache)
Background
To reduce peanut allergy prevalence, infant feeding guidelines now recommend introducing peanuts in an age‐appropriate form (such as peanut butter) as part of complementary feeding. However, due to a lack of randomized trial evidence, most infant feeding and food allergy prevention guidelines do not include tree nuts. The aims of this trial were to determine safety and feasibility of dosage consumption recommendations for infant cashew nut spread introduction.
Methods
This is a parallel, three‐arm (1:1:1 allocation), single‐blinded (outcome assessors), randomized controlled trial. General population term infants were randomized at 6–8 months of age to either a one teaspoon (Intervention 1 n = 59) or increasing dosage regime of one teaspoon at 6–7 months, two teaspoons at 8–9 months, and three teaspoons from 10 months of age onwards (Intervention 2 n = 67) cashew nut spread, both three times per week, or no specific advice on cashew introduction (Control n = 70). At 1 year of age, food challenge proven IgE‐mediated cashew nut allergy was assessed.
Results
Compliance in Intervention 1 (92%) was higher than Intervention 2 (79%), p = .04. Only one infant had delayed (at 5 h) facial swelling and eczema flare to cashew introduction at 6.5 months, but no cashew allergy at 1 year. Only one infant (Control) had cashew allergy at 1 year, and this infant had not been introduced to cashew prior to 12 months of age.
Conclusion
Regular infant consumption of one teaspoon of cashew nut spread three times per week from 6 to 8 months of age was found to be feasible and safe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Telethon Kids Institute, Nedlands, Western Australia, Australia.
- School of Medicine, Crawley, Western Australia, Australia.
- Joondalup Health Campus, Joondalup, Western Australia, Australia.
- School of Medicine, Edith Cowan University, Joondalup, Western Australia, Australia.
- inVIVO Planetary Health, Group of the Worldwide Universities Network (WUN), West New York, New Jersey, USA.
- Department of Immunology and Dermatology, Perth Children's Hospital, Nedlands, Western Australia, Australia.
ORCID-Profile: Debra J Palmer
Förderung
- Australian Food Allergy Foundation
- Channel 7 Telethon Trust
- Commonwealth Government of Australia
- Paul Ramsay Foundation
Zitieren
APA
Palmer, D. J., Silva, D. T., & Prescott, S. L. (2023). Feasibility and safety of introducing cashew nut spread in infant diets—A randomized trial. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.13969
Vancouver
Palmer DJ, Silva DT, Prescott SL. Feasibility and safety of introducing cashew nut spread in infant diets—A randomized trial. Pediatric Allergy and Immunology. 2023. doi:10.1111/pai.13969
BibTeX
@article{Palmer2023,
author = {Palmer, Debra J and Silva, Desiree T and Prescott, Susan L},
title = {Feasibility and safety of introducing cashew nut spread in infant diets—A randomized trial},
journal = {Pediatric Allergy and Immunology},
year = {2023},
doi = {10.1111/pai.13969}
}
EUVIMED